{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:06:02Z","timestamp":1790096762160,"version":"4.0.1"},"reference-count":32,"publisher":"American Chemical Society (ACS)","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012600","name":"ShanghaiTech University","doi-asserted-by":"publisher","award":["2021F0209-000-04"],"award-info":[{"award-number":["2021F0209-000-04"]}],"id":[{"id":"10.13039\/501100012600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015377","name":"Shanghai Key Laboratory of Molecular Imaging","doi-asserted-by":"publisher","award":["18DZ2260400"],"award-info":[{"award-number":["18DZ2260400"]}],"id":[{"id":"10.13039\/501100015377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pulmonary fibrosis remains challenging to detect at an early stage because current clinical imaging relies primarily on high-resolution computed tomography (HRCT), which detects established structural damage rather than active fibrotic remodeling. To address this sensing gap, we engineered and evaluated [68Ga]Ga-HT448, a positron emission tomography (PET) probe based on a high-affinity bicyclic peptide targeting the urokinase-type plasminogen activator receptor (uPAR), a receptor upregulated across multiple cell types during fibrogenesis. Probe performance was assessed through longitudinal PET\/CT imaging in two mechanistically distinct murine models of pulmonary fibrosis (bleomycin-induced and radiation-induced), benchmarked head-to-head against the clinically translated fibroblast activation protein-targeted probe [68Ga]Ga-FAPI-04, and validated against HRCT, histopathology, and immunohistochemistry, including pharmacodynamic assessment during nintedanib therapy. [68Ga]Ga-HT448 exhibited high uPAR binding affinity (KD = 7.85 nM), favorable pharmacokinetics, and low pulmonary background, enabling sensitive detection of increased lung uptake as early as Day 7 post-induction in both models, preceding HRCT-detectable structural changes and correlating strongly with fibrosis severity and uPAR expression. Compared with [68Ga]Ga-FAPI-04, the uPAR-targeted probe [68Ga]Ga-HT448 produced earlier, higher, and more sustained signals during disease progression and demonstrated a significantly greater reduction in signal following antifibrotic treatment (p &amp;lt; 0.001 vs p &amp;gt; 0.05). These findings establish uPAR-targeted PET as a sensitive and pharmacodynamically responsive approach for early sensing and therapeutic monitoring of pulmonary fibrosis.<\/jats:p>","DOI":"10.1021\/acssensors.6c03460","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:01:51Z","timestamp":1790092911000},"source":"Crossref","is-referenced-by-count":0,"title":["Engineering a Bicyclic Peptide-Based Positron Emission Tomography Probe Targeting Urokinase-Type Plasminogen Activator Receptor Enables Early Sensing and Therapeutic Monitoring of Pulmonary Fibrosis"],"prefix":"10.1021","author":[{"given":"Kezhi","family":"Ding","sequence":"first","affiliation":[{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Yang","sequence":"additional","affiliation":[{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyun","family":"Pu","sequence":"additional","affiliation":[{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Liu","sequence":"additional","affiliation":[{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Xie","sequence":"additional","affiliation":[{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2034-5878","authenticated-orcid":true,"given":"Jiawen","family":"Huang","sequence":"additional","affiliation":[{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]},{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0064-775X","authenticated-orcid":true,"given":"Zonghua","family":"Luo","sequence":"additional","affiliation":[{"name":"ShanghaiTech University , , ,","place":["Shanghai, China, 201210"]},{"name":"Shanghai Clinical Research and Trial Center , ,","place":["Shanghai, China, 201210"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2026092212014691800_cit1","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1038\/s41598-017-10062-1","article-title":"Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression Enhances Invasion and Metastasis in RAS Mutated Tumors","volume":"7","author":"Di Mauro","year":"2017","journal-title":"Sci. Rep."},{"key":"2026092212014691800_cit2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-94-017-7215-0_10","volume-title":"Advances in Cancer Biomarkers: From Biochemistry to Clinic for a Critical Revision","author":"McMahon","year":"2015"},{"key":"2026092212014691800_cit3","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.molimm.2011.02.011","article-title":"Participation of the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Neutrophil Transendothelial Migration","volume":"48","author":"Pliyev","year":"2011","journal-title":"Mol. Immunol."},{"key":"2026092212014691800_cit4","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: A Versatile Signalling Orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026092212014691800_cit5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrm2821","article-title":"Regulation of Cell Signalling by uPAR","volume":"11","author":"Smith","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026092212014691800_cit6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jmb.2011.05.026","article-title":"Activation of the Zymogen to Urokinase-Type Plasminogen Activator Is Associated with Increased Interdomain Flexibility","volume":"411","author":"Behrens","year":"2011","journal-title":"J. Mol. Biol."},{"key":"2026092212014691800_cit7","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1007\/s00018-008-7573-9","article-title":"The Urokinase Receptor and Integrins in Cancer Progression","volume":"65","author":"Tang","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"2026092212014691800_cit8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1160\/TH12-08-0546","article-title":"uPAR Regulates Pericellular Proteolysis through a Mechanism Involving Integrins and fMLF-Receptors","volume":"109","author":"Montuori","year":"2013","journal-title":"Thromb. Haemostasis"},{"key":"2026092212014691800_cit9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12967-022-03329-3","article-title":"Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Therapeutic Target in Cancer","volume":"20","author":"Zhai","year":"2022","journal-title":"J. Transl. Med."},{"key":"2026092212014691800_cit10","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/s41467-022-29344-y","article-title":"Crystal Structure and Cellular Functions of uPAR Dimer","volume":"13","author":"Yu","year":"2022","journal-title":"Nat. Commun."},{"key":"2026092212014691800_cit11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.7150\/thno.4218","article-title":"Role of Urokinase Receptor in Tumor Progression and Development","volume":"3","author":"Noh","year":"2013","journal-title":"Theranostics"},{"key":"2026092212014691800_cit12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.rmed.2011.12.011","article-title":"Lung Capillary Blood Volume and Membrane Diffusion in Idiopathic Interstitial Pneumonia","volume":"106","author":"W\u00e9meau-Stervinou","year":"2012","journal-title":"Respir. Med."},{"key":"2026092212014691800_cit13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary Fibrosis: From Pathogenesis to Clinical Decision-Making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol. Med."},{"key":"2026092212014691800_cit14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12890-025-03836-1","article-title":"Incidence and Prevalence of Idiopathic Pulmonary Fibrosis: A Systematic Literature Review and Meta-Analysis","volume":"25","author":"Golchin","year":"2025","journal-title":"BMC Pulm. Med."},{"key":"2026092212014691800_cit15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2967\/jnumed.121.262944","article-title":"Perspective on Fibroblast Activation Protein\u2013Specific PET\/CT in Fibrotic Interstitial Lung Diseases: Imaging Fibrosis\u2014A New Paradigm for Molecular Imaging?","volume":"63","author":"Schmidkonz","year":"2022","journal-title":"J. Nucl. Med."},{"key":"2026092212014691800_cit16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2967\/jnumed.124.267852","article-title":"Molecular Imaging of Pulmonary Fibrosis","volume":"66","author":"Allison","year":"2025","journal-title":"J. Nucl. Med."},{"issue":"1","key":"2026092212014691800_cit17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12931-019-0974-5","article-title":"Absence of Early Metabolic Response Assessed by 18F-FDG PET\/CT after Initiation of Antifibrotic Drugs in IPF Patients","volume":"20","author":"Bondue","year":"2019","journal-title":"Respir. Res."},{"issue":"6","key":"2026092212014691800_cit18","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060726","article-title":"[68Ga]FAPI PET for Imaging and Treatment Monitoring in a Preclinical Model of Pulmonary Fibrosis: Comparison to [18F]FDG PET and CT","volume":"17","author":"Ji","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"11","key":"2026092212014691800_cit19","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1007\/s00259-022-05814-9","article-title":"[68Ga]Ga-FAPI-46 PET for Non-Invasive Detection of Pulmonary Fibrosis Disease Activity","volume":"49","author":"Rosenkrans","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"14","key":"2026092212014691800_cit20","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.Can-15-2973","article-title":"FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3\u2013CCL2 Signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"key":"2026092212014691800_cit21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ijrobp.2024.08.034","article-title":"Using Integrin \u03b1v\u03b26-Targeted Positron Emission Tomography Imaging to Longitudinally Monitor Radiation-Induced Pulmonary Fibrosis In Vivo","volume":"121","author":"Lo","year":"2025","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"issue":"6","key":"2026092212014691800_cit22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41419-023-05876-z","article-title":"Targeting Pathogenic Macrophages by the Application of SHP-1 Agonists Reduces Inflammation and Alleviates Pulmonary Fibrosis","volume":"14","author":"Hong","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"2026092212014691800_cit23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12890-023-02349-z","article-title":"Pulmonary Fibrosis Model of Mice Induced by Different Administration Methods of Bleomycin","volume":"23","author":"Gul","year":"2023","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"2026092212014691800_cit24","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030402","article-title":"Interstitial Macrophages Lead Early Stages of Bleomycin-Induced Lung Fibrosis and Induce Fibroblasts Activation","volume":"12","author":"Lib\u00f3rio-Ramos","year":"2023","journal-title":"Cells"},{"issue":"2","key":"2026092212014691800_cit25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021796","article-title":"The uPA\/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression","volume":"24","author":"Kanno","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"2026092212014691800_cit26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021382","article-title":"Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19","volume":"24","author":"Shmakova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"2026092212014691800_cit27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","article-title":"Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases","volume":"207","author":"Yang","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"2026092212014691800_cit28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","article-title":"uPA and uPAR in Fibrinolysis, Immunity and Pathology","volume":"25","author":"Mondino","year":"2004","journal-title":"Trends Immunol."},{"issue":"1","key":"2026092212014691800_cit29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1165\/ajrcmb.15.1.8679225","article-title":"Differential Expression of the Urokinase Receptor in Fibroblasts from Normal and Fibrotic Human Lungs","volume":"15","author":"Shetty","year":"1996","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"11","key":"2026092212014691800_cit30","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1681\/ASN.2020060829","article-title":"Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI","volume":"31","author":"Azam","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"Suppl 69","key":"2026092212014691800_cit31","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2025.PA5086","article-title":"Circulating Urokinase-Type Plasminogen Activator Receptor (uPAR) Associates with Progression of Idiopathic Pulmonary Fibrosis (IPF)","volume":"66","author":"Todd","year":"2025","journal-title":"Eur. Respir. J."},{"issue":"7","key":"2026092212014691800_cit32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7150\/thno.3791","article-title":"Structure-Driven Design of Radionuclide Tracers for Non-Invasive Imaging of uPAR and Targeted Radiotherapy: The Tale of a Synthetic Peptide Antagonist","volume":"3","author":"Ploug","year":"2013","journal-title":"Theranostics"}],"container-title":["ACS Sensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acssensors.6c03460","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ascefj\/article-pdf\/doi\/10.1021\/acssensors.6c03460\/68605706\/se-2026-034606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ascefj\/article-pdf\/doi\/10.1021\/acssensors.6c03460\/68605706\/se-2026-034606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:10:05Z","timestamp":1790093405000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ascefj\/article\/doi\/10.1021\/acssensors.6c03460\/5435681\/Engineering-a-Bicyclic-Peptide-Based-Positron"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1021\/acssensors.6c03460","relation":{},"ISSN":["2379-3694"],"issn-type":[{"value":"2379-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}